136 related articles for article (PubMed ID: 16367908)
1. Identification of tumor associated antigens recognized by IgG from tumor-infiltrating B cells of lung cancer: correlation between Ab titer of the patient's sera and the clinical course.
Mizukami M; Hanagiri T; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; Yasuda M; Takenoyama M; Sugio K; Yasumoto K
Cancer Sci; 2005 Dec; 96(12):882-8. PubMed ID: 16367908
[TBL] [Abstract][Full Text] [Related]
2. Malignant mesothelioma-associated antigens recognized by tumor-infiltrating B cells and the clinical significance of the antibody titers.
Shigematsu Y; Hanagiri T; Kuroda K; Baba T; Mizukami M; Ichiki Y; Yasuda M; Takenoyama M; Sugio K; Yasumoto K
Cancer Sci; 2009 Jul; 100(7):1326-34. PubMed ID: 19432887
[TBL] [Abstract][Full Text] [Related]
3. Tumor-infiltrating B lymphocytes as a potential source of identifying tumor antigen in human lung cancer.
Yasuda M; Takenoyama M; Obata Y; Sugaya M; So T; Hanagiri T; Sugio K; Yasumoto K
Cancer Res; 2002 Mar; 62(6):1751-6. PubMed ID: 11912150
[TBL] [Abstract][Full Text] [Related]
4. Antigens recognized by IgG derived from tumor-infiltrating B lymphocytes in human lung cancer.
Yasuda M; Mizukami M; Hanagiri T; Shigematsu Y; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; Takenoyama M; Sugio K; Yasumoto K
Anticancer Res; 2006; 26(5A):3607-11. PubMed ID: 17094490
[TBL] [Abstract][Full Text] [Related]
5. Effect of IgG produced by tumor-infiltrating B lymphocytes on lung tumor growth.
Mizukami M; Hanagiri T; Shigematsu Y; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; Yasuda M; So T; Takenoyama M; Sugio K; Yasumoto K
Anticancer Res; 2006; 26(3A):1827-31. PubMed ID: 16827114
[TBL] [Abstract][Full Text] [Related]
6. A different pattern of cytotoxic T lymphocyte recognition against primary and metastatic tumor cells in a patient with nonsmall cell lung carcinoma.
So T; Takenoyama M; Ichiki Y; Mizukami M; So T; Hanagiri T; Sugio K; Yasumoto K
Cancer; 2005 Jan; 103(1):200-8. PubMed ID: 15573370
[TBL] [Abstract][Full Text] [Related]
7. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating B-cell-derived IgG recognizes tumor components in human lung cancer.
Imahayashi S; Ichiyoshi Y; Yoshino I; Eifuku R; Takenoyama M; Yasumoto K
Cancer Invest; 2000; 18(6):530-6. PubMed ID: 10923101
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of antibody against a SEREX-defined antigen (UOEH-LC-1) on lung cancer xenotransplanted into severe combined immunodeficiency mice.
Mizukami M; Hanagiri T; Yasuda M; Kuroda K; Shigematsu Y; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; So T; Takenoyama M; Sugio K; Yasumoto K
Cancer Res; 2007 Sep; 67(17):8351-7. PubMed ID: 17804751
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
Preuss KD; Zwick C; Bormann C; Neumann F; Pfreundschuh M
Immunol Rev; 2002 Oct; 188():43-50. PubMed ID: 12445280
[TBL] [Abstract][Full Text] [Related]
11. Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method.
Nakatsura T; Senju S; Ito M; Nishimura Y; Itoh K
Eur J Immunol; 2002 Mar; 32(3):826-36. PubMed ID: 11870627
[TBL] [Abstract][Full Text] [Related]
12. Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer.
Lee SY; Williamson B; Caballero OL; Chen YT; Scanlan MJ; Ritter G; Jongeneel CV; Simpson AJ; Old LJ
Cancer Immun; 2004 Nov; 4():13. PubMed ID: 15546177
[TBL] [Abstract][Full Text] [Related]
13. Anti-vascular endothelial growth factor receptor (VEGFR) 2 autoantibody identification in glioblastoma patient using single B cell-based antibody gene cloning.
Iizuka A; Komiyama M; Oshita C; Kume A; Ashizawa T; Mitsuya K; Hayashi N; Nakasu Y; Yamaguchi K; Akiyama Y
Immunol Lett; 2014; 159(1-2):15-22. PubMed ID: 24534640
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous cellular and humoral immune response against mutated p53 in a patient with lung cancer.
Ichiki Y; Takenoyama M; Mizukami M; So T; Sugaya M; Yasuda M; So T; Hanagiri T; Sugio K; Yasumoto K
J Immunol; 2004 Apr; 172(8):4844-50. PubMed ID: 15067062
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer-related changing profile of B-cell epitopes recognized on mucosal antigens: the Der p1 model.
Michils A; Yernault JC; El Chaarani B; Van Laethem JL; Crockaert F; Gossart B; Duchateau J
Cancer; 1995 Oct; 76(7):1166-75. PubMed ID: 8630893
[TBL] [Abstract][Full Text] [Related]
16. [Screening and identification of human lung cancer-related antigens].
Liu HY; Peng LP; Ran YL; Zhang LZ; Zhang DC; Zhu YK; Yang ZH
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):171-5. PubMed ID: 12006991
[TBL] [Abstract][Full Text] [Related]
17. Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer.
Güre AO; Stockert E; Scanlan MJ; Keresztes RS; Jäger D; Altorki NK; Old LJ; Chen YT
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4198-203. PubMed ID: 10760287
[TBL] [Abstract][Full Text] [Related]
18. Antigens recognized by autologous antibodies of patients with soft tissue sarcoma.
Segal NH; Blachere NE; Shiu HY; Leejee S; Antonescu CR; Lewis JJ; Wolchok JD; Houghton AN
Cancer Immun; 2005 Mar; 5():4. PubMed ID: 15745419
[TBL] [Abstract][Full Text] [Related]
19. Antigen Specificity and Clinical Significance of IgG and IgA Autoantibodies Produced
Garaud S; Zayakin P; Buisseret L; Rulle U; Silina K; de Wind A; Van den Eyden G; Larsimont D; Willard-Gallo K; Linē A
Front Immunol; 2018; 9():2660. PubMed ID: 30515157
[TBL] [Abstract][Full Text] [Related]
20. Antigens recognized by autologous antibody in patients with renal-cell carcinoma.
Scanlan MJ; Gordan JD; Williamson B; Stockert E; Bander NH; Jongeneel V; Gure AO; Jäger D; Jäger E; Knuth A; Chen YT; Old LJ
Int J Cancer; 1999 Nov; 83(4):456-64. PubMed ID: 10508479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]